There are also implications for the community because almost all people who go to prison return to the community from which they come, and they should have the opportunity to address their AoD use before they return. 5, 6 Prison presents an opportunity to engage a group with a high proportion of people who have a history of AoD misuse and who are otherwise difficult to access.
Although prison-based AoD group treatment programs are available in all Australian jurisdictions, there is limited aggregated data on rates of attendance. The only national figures are from the Australian Institute of Health and Welfare (AIHW), which showed that only 8% of people leaving prison had received treatment for alcohol misuse, with there being no corresponding figure for drug misuse treatment. 7 Australian governments are responsible for the provision of treatment services in prisons, either directly or by contracting the services from another provider. 8, 9 Treatment services in prisons can differ greatly depending on factors such as location within the jurisdiction and size of the inmate population.
Four major types of behavioural treatment are provided in Australian prisons. Psychoeducational programs give health information in a lecture-type format with limited interaction. [9] [10] [11] Cognitive behavioural therapy (CBT) is interactive and aims to assist individuals to re-evaluate their problem behaviour and develop different behaviours. [9] [10] [11] Twelve-step programs such from alcohol or drug use. 12 Motivational enhancement programs are interactive and aim to build and maintain motivation for behavioural change. [9] [10] [11] Treatment is delivered in different formats and combinations of formats including one-to-one counselling, group sessions, therapeutic communities and residential treatment programs. Participants/inmates are housed separately from the rest of the prison population while in a Therapeutic Community (TC) or residential program; the core difference is that in a TC the inmates are part of a community and contribute to the running of the TC. [9] [10] [11] In addition to behavioural treatments, prison-based opioid substitution treatment is available in most Australian jurisdictions, with methadone the predominant pharmacotherapy but buprenorphine is also available. Methadone is a proven effective treatment internationally, showing great benefit over many years. 13 In
Australia, treatment can be initiated in prison and continued in the community. It is also possible for people already on methadone in the community to continue methadone when entering prison.
The importance of providing the most costeffective combination of prison-based AoD treatment is reflected in the rising rates of imprisonment in Australia: it has increased from 135.4 per 100,000 in 2007 to 169.2 per 1000,000 in 2017. 14 Australia's Indigenous peoples, Aboriginal and Torres Strait Islanders, had both a far higher rate of imprisonment in 2007 (1,540.6 per 100,000) and a larger increase in the decade to 2017, where rates were 2,141.6 per 1000,000. 14 Alcohol and other drug use has been identified as one of the contributing factors to the high levels of Indigenous imprisonment. 15 The high level of imprisonment of Indigenous people is also evident in comparable countries such as New Zealand and Canada. 16 Given the importance of providing costeffective AoD treatment in prison, a metaanalysis by Pearson and Lipton 17 in 1999 and a systematic review by Mitchell et al. 2006 , updated 2012 18, 19 both concluded that the TC mode of delivery was most likely to reduce AoD use. These reviews focused on re-imprisonment being the primary outcome or interest, rather than AoD use and did not assess the methodological quality of the included studies. The current systematic review has four aims. First, to identify evaluations of prison-based AoD treatment published between 1995 and 2015 (inclusive).
Second, to describe the key characteristics of the identified studies, including study design. Third, to appraise their methodological quality against standard criteria. Fourth to identify from the methodically-sound evaluations the type of prison-based AoD treatment that has the most evidence for its effectiveness.
Methods

Identification of publications
A Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) compliant literature search was undertaken to identify relevant papers published between 1995 and 2015 inclusive. 20 As summarised in Figure 1 , 45 databases were searched via seven platforms: i) Informit (3,201 references); ii) OVID & Cochrane Library (2,027 references); iii) Campbell Library (21 references); iv) Web of Science (1,950 references); v) CINAHL (2,412 references); vi) Scopus (2,824 references); and vii) Project Cork (612 references). Word-strings were used to search the databases, grouped into four domains: i) research participant groups and setting; ii) AoD use disorders; iii) provision of treatment or care; and iv) identifying the paper as being either research or evaluation. The search was limited to those studies published between 1 January 1995 and 31 December 2015, and available in English. Grey literature was excluded because it represents a substantial body of literature with a low probability that methodologically rigorous evaluations would be published there and not in the peer reviewed literature.
This search strategy identified 13,047 references that were stored and managed in Endnote. 21 On entry into Endnote, duplicates were identified and deleted, and a manual search of titles and year of publication was undertaken to identify remaining duplicates: 7,898 duplicates were removed leaving 5,149 references.
Application of inclusion criteria
Five inclusion criteria were specified: 1) prison-based AoD treatment for inmates (studies on co-morbidity or mental health treatments were excluded to maintain the focus on AoD); 2) adults (juvenile detention programs may need to be substantially different to account for their different developmental stage); 3) men, or men and women (women-only studies were excluded because their different AoD treatment needs means a separate systematic review for them is more appropriate); 4) report previously unpublished, primary data or analysis; 5) only behavioural treatments (pharmacotherapy treatment was excluded because behavioural treatments are more frequently provided and ought to be given in addition to, not instead of, pharmacotherapy). As the authors wanted to catalogue the range of studies designs used in this field of research, there was no inclusion or exclusion criteria based upon study design. There was no inclusion or exclusion criteria based upon AoD use outcome measures due to the broad number of measures used, and because many studies used re-imprisonment as the primary outcome measure in the previous reviews. 17, 19 The titles and key words of the 5,149 references were examined both electronically and manually in Endnote. For the electronic search, key words to identify those papers that did not meet the inclusion criteria were searched specifically infant, child*, adolescent*, juvenile*, disease*, infect*, firearm*, fraud*, cancer* and maternal health. These electronic and manual reviews of paper titles identified 4,391 studies that did not meet all the inclusion criteria. The abstracts of the 758 remaining studies were then examined manually, which identified another 513 studies that did not meet all the inclusion criteria, leaving 245 studies.
The full text versions of these 245 studies were examined and a further 220 excluded because they were review papers (n=23), discussed the theory of AoD treatment provision only (n=20), discussed treatment concepts generally (n=85), focused only on screening and clinical issues (n=29), or did not report original data, post-prison outcomes or describe the treatment program in sufficient detail to allow the possibility of replication (n=63).
Examination of reference lists
The reference lists of the reviews by Pearson and Lipton 17 and Mitchell et al. 18, 19 cited in the introduction, were examined but no new relevant papers were identified. Consequently, 25 papers were identified as being eligible for critical review.
Characteristics of prison-based alcohol and other drug treatment programs
© 2019 The Authors time periods (1995-2005 and 2006-2015) ; ii) country of origin; iii) gender of participants; iv) format of treatment provision; v) type of treatment provided; vi) entry requirements; vii) treatment duration (all converted to days to facilitate comparison, where one month is 30 days, six months is 182 days and nine months is 274 days); viii) group size; ix) the evaluation methods used; and x) whether the program was ongoing or established only for the purpose of an evaluation.
Critical appraisal of methodological quality
Assessment criteria for quantitative papers
The methodological quality of quantitative papers was appraised using two methods: the Dictionary for the Effective Public Health Practice Project Quality Assessment Tool for Quantitative Studies (QATQS), 22, 23 and a global rating. The QATQS has eight criteria, against which the methodological strength of studies is assessed as strong, moderate or weak: A) selection bias; B) study design; C) confounders; D) blinding of participants and research staff; E) data collection methods; F) withdrawal and dropout of participants; G) treatment integrity; and H) data analysis. For the global rating, papers assessed as weak on two or more criteria were classified as 'weak'; those with one weak criteria were classified as 'moderate'; and those with no weak ratings against any criterion were classified as 'strong' . 22 Due to the difficulty in blinding AoD treatment in prisons, criterion D was excluded.
A random sample of 54% (n=13) of the 24 included quantitative papers were selected and re-reviewed by a blinded coder (MS) using just the definitions provided for the methodological criteria. Initially there was 92% (n=12) agreement between MD and MS on the global rating. The difference in ratings was resolved through discussion, with the difference arising from ambiguous reporting of methods in the paper.
Assessment criteria for qualitative paper
As distinct from the previous reviews, this paper uses Long and Godfrey's evaluation tool to assess published qualitative evaluations, which has four criteria: 1) phenomenon studied and context; 2) ethics; 3) data collection, analysis and potential research bias; and 4) policy and practical implications. Rather than a rating scale, an assessment report is used to draw conclusions about the methodological strength of qualitative studies. 
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Data extraction process
Results
A total of 25 evaluations of prison-based AoD treatment were published between 1995 and 2015 (inclusive).
Characteristics of prison-based alcohol and other drug treatment programs
The characteristics of prison-based AoD treatment programs, as summarised in Table  1 
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Country of origin: Over half the evaluations were of programs in the United States 35 Croatia, 30 Japan, 40 Poland, 49 the United Kingdom (Wales), 44 and South Korea. 42 Gender of participants: Eight studies included samples of both of men and women, 25, 26, 29, 31, 34, 38, 39, 45 meaning the remaining 17 were male participants only.
Format of treatment provided: Four treatment format modes were described: i) residential (n=6); 25, 26, 28, 29, 37, 38 ii) therapeutic prison (n=3); 30, 39, 40 iii) therapeutic community (n=8); [31] [32] [33] [34] [41] [42] [43] 48 and iv) group treatment (n=7). 35, 36, [44] [45] [46] [47] 49 Treatment approach: Seven different treatment approaches were described: i) CBT, or a derivative such as cognitive social therapy (n=8); 25 vi) a computerised educational program (n=1); 45 and vii) a Native American therapeutic healing program (n=1). 36 Several studies only described the treatment approach as being a TC with limited other detail given, even though a TC is not necessarily a treatment approach in the same way as the other treatments (n=7). [31] [32] [33] [34] 42, 43, 48 In terms of postprison follow-up treatment, three TCs and one residential program included post-prison care, 28, 31, 32, 34 and a therapeutic prison had 12-step program attendance as a condition for release (although post-prison attendance was not monitored). 30 Treatment entry requirements: Screening for history of AoD use routinely occurred at prison entry, resulting in clinical referral, which was the most common route to treatment (n= 16). Once referred to treatment, the majority of treatments required inmates to voluntarily agree to enter the program. There were four exceptions where attendance could be mandated by Courts, or in once case by psychologists. 29, 30, 33, 38 Treatment duration: There was wide variation; residential ranged from 42 to 365 days, TCs from 182 to 532 days, therapeutic prison from 10 to 30 days and group treatments from 30 to 140 days.
Group size: Most studies did not report on their group size (n=20). For the five that did, group sizes ranged from 1 to 30, with 30 being the most common. 26, 37, 38, 40, 44 Evaluation methods used: Twenty-four used quantitative methods and one qualitative. 27 Ongoing or evaluation project only: Twentyone studies evaluated ongoing treatment programs [25] [26] [27] [28] [29] [30] [31] [32] [33] 35, 37, 38, [40] [41] [42] [43] 45, 46, [48] [49] [50] and four were evaluations of a specific type of AoD treatment. 36, 39, 44, 47 Critical appraisal of methodological quality
Quantitative evaluations
Five of the 24 quantitative papers had a strong study design (column 4 Table 2 ) with four being clinical controlled trials 34, 42, 45, 47 and one a randomised controlled trial. 44 Thirteen study designs rated as moderate and six as weak. Allocation of participants into treatment or control groups occurred after recruitment in the five strong study design papers. 34, 42, 44, 45, 47 The other papers had treatment group participants who had already been allocated to treatment through clinical referral processes before inclusion in the study; controls in these papers were specifically recruited by researchers, or were identified retrospectively from prison departmental data files. Data collection was rated as strong for 12 papers, half of these were TC, 32, 34, 37, [39] [40] [41] [42] [43] [44] [46] [47] [48] and moderate for one; 49 all these strong and moderate rated papers used recognised survey tools, with nine of those also using routinely collected prison data. None of the elven papers rated as weak used recognised survey tools. Notably, one paper supplemented self-reported data on social behaviour of participants with third-party data. 35 In total, 53 data collection tools were catalogued (Supplementary Figure 1) .
The Intervention Integrity column (Table  2) reports treatment exposure level, the integrity (or consistency) and unintended exposure to similar treatment/s. The exposure level to the treatment was specifically reported in just four papers. 25, 37, 44, 45 Thirteen described the treatment group participants as completed or graduated and as such they had received the required level of treatment exposure. 28, 29, 32, 34, [38] [39] [40] [41] [42] [43] [46] [47] [48] Only two reported specifically on integrity, which is about the consistence of the delivered treatment; 43, 45 however, most of the treatment regimens reported having a curriculum. There was no mention of a curriculum for one paper. 
Qualitative evaluation
Key findings for the only qualitative paper, by Staton et al. 27 were not stated concisely.
The article was a general summary of a residential treatment program with inmate and staff participants. The methodological framework was vague, with no description of the participant group and no detail about the context of the interviews -for example, whether data were collected via audio recording or by written notes, or whether results were for the inmate or staff participants. The authors reported the program as successful in changing the behaviour so that participants were less likely to abuse AoD upon release, however postrelease data were not presented.
Effectiveness of AoD treatment
The papers that were ranked on QATSQ as strong or moderate were grouped by AoD outcome measured in Table 3 Three reported reduced AoD use among the treatment group, one was residential AoD use harm-reduction self-efficacy was measured in five papers, 41, 42, 45, 47, 48 drug use harm reduction was the focus of four of these papers. 41, 42, 47, 48 Satisfaction and perception of treatment were measured in one paper 45 with other measures including,
but not limited to, social functioning in three papers, 34, 37, 41 problem solving in one (n=3), 42 and psychological functioning, including depression in two papers.
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Discussion
Twenty-five studies were identified for inclusion in this systematic review of prisonbased AoD behavioural treatment. The characteristics of the studies were described and the methodological quality assessed. The type of prison-based AoD treatment that had the most evidence for its effectiveness was identified, which was prison-based TC. The reviews by Mitchell et al. 18, 19 as well as the meta-analysis by Pearson and Lipton et al. 17 made the same conclusion about the most effective treatment. By reviewing the methodological quality of papers this review has added to the previous work of Mitchell et al. 18, 19 25, 37 The methodological quality of evaluations of the therapeutic community treatments was clearly higher than the other treatment approaches, with seven of the eight (88%) rated as methodologically sound, compared to 43% of group treatment and 30% of residential treatment approaches.
Of the 12 papers that had AoD outcome measures six were assessed to be methodologically moderate or strong and four had statistically significant results. 19, 25, 31, 32, 34, 41, 45, 47 Of these papers, three reported a statistically significant reduction of AoD use post-prison; the Pelissier et al. 25 study reported on treatment that was in a residential setting, while the studies by Inciardi et al. 31 and Knight et al. 32 both reported on treatment in TC settings. All three reported on treatments that used a form of CBT. Measures for drug use post-prison were urinalysis results, one study also including refusals to undertake urinalysis as a positive test for drugs. 25 Alcohol-use measures were self-reported, either directly by participant or from file information. There were no medical tests for alcohol use.
It is not possible to report on the AoD use of people lost to follow-up, and the three methodologically-sound studies reporting statistically significant reduction in AoD use post-prison 25,31,32 had significant loss to follow-up. The paper by Inciardi et al. 31 reported a total of 1,002 eligible participants with 448 (44.7%) participants interviewed at follow-up; while Pelissier et al. 25 paper identified 3,112 eligible participants, reporting on 1,569 (50.4%) participants at follow-up, and Knight et al. 32 paper had a total of 603 eligible participants, with 414 (68.7%) at follow-up. The only methodologicallysound papers that reported reduced AoD use were Pelissier et al., 25 Knight et al. 32 and
Inciardi et al. 31 All papers reported on TC or residential treatment programs, used forms of CBT and had durations of 274 days (9 months) to 365 days (12 months). All three had aftercare.
There are multiple reasons for the loss to follow-up that were reported in the eight studies with post-prison data. Research participants may not want to be associated with the criminal justice system once they are released and they may have higher day-today priorities than taking part in research. Additionally, people in this population may not wish to admit to the use of illicit drugs, which is an illegal activity. Improving followup in future studies is critical as it would help understand the effect of treatment programs. 34 paper reported on a study that had n=715 participants, with n=425 in the treatment groups and n=290 in the control group. The Wexler paper categorised the treatment and controls into five sub-groups: A) controls (n=425); B) dropped out of treatment in prison (n=98); C) completed treatment in prison but did not attend aftercare (n=194); D) completed prison treatment but dropped out of aftercare (n=36), and E) completed both prison-based TC and post-prison care (n=97) (35) . All 715 participants were interviewed at 12-month follow-up. 34 This either gives 100% follow-up, or it is possible there were more participants but only those with whom they had followup interviews were included in the analysis. Nonetheless, Wexler et al. 34 conducted an intention-to-treat analysis of the participants, with TC and aftercare dropouts included in the analysis, and was this was the only study to do so. The paper by Pelissier et al. 25 identified n=3,112 eligible participants, but , undertook such an analysis for prison-based AoD treatment programs and found no statistically significant reduction in re-imprisonment. 51 There was, however, a trend that indicated reduced likelihood of re-imprisonment in the Bureau of Crime Statistics report and it is possible that with a larger sample size the trend could become statistically significant. Non-AoD treatment programs that focus on areas including interpersonal violence and anger management could also potentially contribute to reduced re-imprisonment. Future intention-to-treat analysis as well as a survival analysis would also yield more accurate results for reporting on reduction of re-imprisonment.
Prison is a challenging environment in which to conduct research, with multiple ethical and methodological challenges. Five of the total 25 papers had a strong study design with one being a randomised controlled trial (RCT) 44 and the others clinical controlled trials (CCT). 34, 37, 42, 45, 47 The RCT by Bowes et.al. 44 enrolled participants voluntarily and then randomly assigned them to the treatment or control groups, with those in the control group receiving standard behavioural AoD use treatment so as not to deprive them of treatment. This method is possibly the most viable way to conduct a randomised controlled trial in a prison environment. However, the Bowes et al. 44 study did not have post-prison follow-up. A future RCT with a similar design that has post-prison followup could make a significant contribution to the understanding of the effectiveness of prison-based AoD treatment.
Despite minority populations (for example, African-Americans and Indigenous Peoples) being over-represented in prison populations, this study found that only two treatment evaluations focused on these minority groups: a US study related to First Nations peoples; 36 and an Australian study in which 87% of the intervention group and 100% of the control group were Indigenous. 35 Although the authors of both papers discussed likely positive effects, neither rated globally as being methodologically sound, meaning their results remain inconclusive. Furthermore, no US papers specifically focused on African-Americans, despite their over-representation in the prison system. 
Conclusion
The methodological quality of published evaluations of prison-based behavioural AoD use programs has improved in the past decade. TC is the treatment format that has been evaluated using the strongest methodological techniques and for which the outcomes are most positive. The treatment type with the most evidence for its effectiveness is CBT. There is still a pressing need for methodologically-sound evaluations of treatment programs for Indigenous Peoples, given their over-representation in prisons globally and their relatively poor health status compared to non-Indigenous populations. 54 There were no economic evaluations to weigh the benefits of these programs against their costs. For prisonbased behavioural AoD treatment programs for men, current best evidence supports the provision of CBT in TCs or a residential context. Post-prison treatment appears to be a promising addition to in-prison treatment.
